Politico reports that Republicans have joined Democrats in blaming large pharmacy groups, including CVS, for high drug prices. The article points to rising bipartisan political pressure on pharmacy benefit managers, which play a major role in the US drug supply chain.
This matters for senior executives in healthcare and pharma, as it signals a shift in the political environment. Bipartisan scrutiny may lead to tougher regulation or changes in how pharmacy benefit managers operate. Leaders should monitor for possible policy changes affecting pricing, contracts and market access.
